Trinity Delta You searched for arecor

Arecor Therapeutics

Arecor, a revenue-generating clinical-stage drug developer, has an in-house and partnered pipeline of enhanced products and portfolio of technology partnerships enabled by its proprietary formulation platform Arestat.

Continued delivery with key AT278 data due in Q423

Arecor Therapeutics | Update | 20 April 2023

Hikma licence milestone achieved

Arecor Therapeutics | Update | 13 January 2023

Getting the chemistry right

Arecor Therapeutics | Outlook | 20 December 2022

Specialty Hospital products formulation collaboration

Arecor Therapeutics | Lighthouse | 10 November 2022

AT247 Phase I pump data confirms promising profile

Arecor Therapeutics | Lighthouse | 11 October 2022

Broadening opportunities and preparing for the future

Arecor Therapeutics | Update | 21 September 2022

Key clinical diabetes events on track for H222

Arecor Therapeutics | Lighthouse | 8 September 2022

Acquisition of Tetris Pharma and £6m equity raise

Arecor Therapeutics | Lighthouse | 01 August 2022

AT278 hits the sweet spot

Arecor Therapeutics | Update | 31 May 2022